BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21263056)

  • 1. Antibiotics cure anthrax in animal models.
    Weiss S; Kobiler D; Levy H; Pass A; Ophir Y; Rothschild N; Tal A; Schlomovitz J; Altboum Z
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1533-42. PubMed ID: 21263056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
    Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J
    Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs.
    Altboum Z; Gozes Y; Barnea A; Pass A; White M; Kobiler D
    Infect Immun; 2002 Nov; 70(11):6231-41. PubMed ID: 12379702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
    Henning LN; Carpenter S; Stark GV; Serbina NV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
    Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR
    Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization.
    Kobiler D; Gozes Y; Rosenberg H; Marcus D; Reuveny S; Altboum Z
    Infect Immun; 2002 Feb; 70(2):544-60. PubMed ID: 11796581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits.
    Weiss S; Kobiler D; Levy H; Marcus H; Pass A; Rothschild N; Altboum Z
    Infect Immun; 2006 Jan; 74(1):394-8. PubMed ID: 16368995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
    Skoble J; Beaber JW; Gao Y; Lovchik JA; Sower LE; Liu W; Luckett W; Peterson JW; Calendar R; Portnoy DA; Lyons CR; Dubensky TW
    Infect Immun; 2009 Apr; 77(4):1649-63. PubMed ID: 19168734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
    Marcus H; Danieli R; Epstein E; Velan B; Shafferman A; Reuveny S
    Infect Immun; 2004 Jun; 72(6):3471-7. PubMed ID: 15155654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and novel strategies in vaccine development and treatment of anthrax.
    Chitlaru T; Altboum Z; Reuveny S; Shafferman A
    Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
    Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.
    Mytle N; Hopkins RJ; Malkevich NV; Basu S; Meister GT; Sanford DC; Comer JE; Van Zandt KE; Al-Ibrahim M; Kramer WG; Howard C; Daczkowski N; Chakrabarti AC; Ionin B; Nabors GS; Skiadopoulos MH
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5684-92. PubMed ID: 23979731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.
    Corey A; Migone TS; Bolmer S; Fiscella M; Ward C; Chen C; Meister G
    Toxins (Basel); 2013 Jan; 5(1):120-38. PubMed ID: 23344456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax spores make an essential contribution to vaccine efficacy.
    Brossier F; Levy M; Mock M
    Infect Immun; 2002 Feb; 70(2):661-4. PubMed ID: 11796596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.